Hence, although further research is needed, we speculate that PRRX1 and the activation of β-catenin/TCF7L2 may regulate the maximal activation of the SPARC promoter in melanoma cells, and maybe that of other mesenchymal genes. Here, TCF7L2 is linked to melanoma.